Connect AccountAll persons or entities that purchased, or otherwise acquired, the stock of Y-mAbs Therapeutics, Inc. (“Y-mAbs”) between October 6, 2020 and October 28, 2022, both dates inclusive.
Preliminarily Approved
October 05, 2020 - January 26, 2023
October 28, 2024
October 07, 2024
Strategic Claims Services
Y-mAbs Therapeutics, Inc. Securities Litigationc/o Strategic Claims ServicesP.O. Box 230600 N. Jackson St., Ste. 205Media, PA 19063
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.